Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,110 | -73,726 | -42,967 | -60,098 | -55,609 |
| Depreciation Amortization | 1,691 | 1,754 | 1,638 | 1,580 | 1,846 |
| Accounts receivable | 950 | -2,240 | -872 | -106 | 73 |
| Accounts payable and accrued liabilities | -6,122 | 2,120 | 9,389 | 3,061 | -333 |
| Other Working Capital | -3,848 | 15,456 | 10,736 | 2,422 | 13,653 |
| Other Operating Activity | -3,376 | 35,480 | 8,574 | 14,049 | 5,028 |
| Operating Cash Flow | $-37,814 | $-21,156 | $-13,503 | $-39,093 | $-35,342 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36 | -116 | -13 | 242 | -11 |
| PPE Investments | -609 | -916 | -355 | -97 | -270 |
| Purchase Sale Intangibles | -9 | -2 | -10 | -1 | -6 |
| Other Investing Activity | -9 | -2 | -10 | 0 | -6 |
| Investing Cash Flow | $-654 | $-1,033 | $-378 | $145 | $-286 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 48,574 | N/A | 162 | N/A | N/A |
| Debt Repayment | -4,015 | -3,328 | -3,216 | -3,837 | -3,352 |
| Common Stock Issued | 1,737 | N/A | 65,105 | N/A | 51 |
| Other Financing Activity | -3,963 | -2,229 | -11,431 | -2,117 | -2,828 |
| Financing Cash Flow | $42,333 | $-5,557 | $50,620 | $-5,954 | $-6,129 |
| Exchange Rate Effect | -455 | 102 | -55 | 87 | 76 |
| Beginning Cash Position | 56,272 | 81,464 | 44,794 | 88,419 | 140,968 |
| End Cash Position | 59,681 | 53,820 | 81,479 | 43,606 | 99,287 |
| Net Cash Flow | $3,409 | $-27,643 | $36,685 | $-44,813 | $-41,681 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,814 | -21,156 | -13,503 | -39,093 | -35,342 |
| Capital Expenditure | -609 | -916 | -355 | -97 | -270 |
| Free Cash Flow | -38,422 | -22,072 | -13,858 | -39,190 | -35,611 |